DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Pfizer Limited — Outcome of Board Meeting

NSE 40 min ago·28 Jul 2026, 8:34 am

Pfizer

Pfizer Limited has informed the stock exchanges that its board has approved the financial results for the period ending June 30, 2026. This announcement signals that the company is in the process of finalizing its accounts for the quarter, which will likely include updates on revenue, expenses, and net profit. Investors should note that the specific figures are not yet disclosed in this filing.

This update is significant as it provides the first official confirmation of the company's performance for the quarter. Retail investors will be looking for these numbers to gauge the company's operational health and growth trajectory. The market will closely watch for any commentary on sales trends or strategic shifts in the upcoming official press release.

Investors should wait for the detailed financial results and management commentary to be released. This will offer clarity on the company's performance and future outlook. Until then, it is advisable to monitor the official press release for the complete data and any guidance provided by the management.